Clinical Trial Update: Markers of Favorable Response to Complement Inhibitors Therapy

View source ↗

Summary

A clinical trial focused on markers predicting favorable response to complement inhibitor therapy in generalized myasthenia gravis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Complement inhibitors (complement inhibition therapy)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Myasthenia Gravis, Generalized | Status: RECRUITING